Programme WEDNESDAY, 14 FEBRUARY 2018

IMAGING COURSE

08:30 Imaging intermediate AMD and subclinical neovascularization

08:50 Different CNV types by OCT-A and evaluation of their activity without use of fluorescein angiography

09:10 “Smart-check” of the imaging to assess the response to AMD treatment

09:30 OCT-A findings of PCV and changes under treatment

09:50 OCT-A findings in CSCR, CNV in CSCR, Mactel I and II

10:10 Clinical value of the imaging assessment of the choroid

10:30 COFFEE BREAK

11:00 Peculiar characteristics of myopic CNV on OCT-A and assessment of response to anti-VEGF treatment

11:20 Managing irvine-gass: OCT assessment of macula prior and after cataract surgery and response to treatment

11:40 Challenges in interpretation of OCT-A images in AMD

DME IN REAL LIFE

12:00 New aspects of biomicroscopic modification of macular stroma and vascularization in the progression of ME

12:30 Correlation of inflammation biomarkers and the stage of ME

13:00 LUNCH

14:00 DME in imaging and OCT/OCT-A: what is important to know

14:30 Intravitreal steroids: biological and clinical differences

15:00 COFFEE BREAK

15:30 Real life data of DME intravitreal treatments and patients management

16:00 – 16:30 Intravitreal treatment: burden for patients and payers